Search results

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

The indication of ulipristal acetate 5mg for uterine fibroids has been further restricted due to the risk of serious liver injury and liver failure, with some cases requiring liver transplantation.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

Pregabalin has been associated with infrequent reports of severe respiratory depression, including some cases without the presence of concomitant opioid medicines. Patients with compromised...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

Information on the newly launched Safer Medicines in Pregnancy and Breastfeeding Consortium and a new report on optimising data on medicines used during pregnancy.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

When children receiving replacement therapy for adrenal insufficiency are being switched from hydrocortisone tablets to Alkindi granules, parents or carers should be informed of the need to be extra...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

A summary of letters and drug alerts recently sent to healthcare professionals.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 18 February 2021

A summary of advice recently issued by the MHRA relating to coronavirus (COVID-19), up to 16 February 2021.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

A review of the risks of major congenital malformations and of adverse neurodevelopmental outcomes for antiepileptic drugs by the Commission on Human Medicines has confirmed that lamotrigine...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

Liver monitoring requirements and discontinuation criteria for fingolimod have been updated following reports of serious liver injury. Fatal cases of encephalitis and meningitis caused by herpes...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

The monitoring requirements and discontinuation criteria for dimethyl fumarate (Tecfidera) have been strengthened following a small number of reports of progressive multifocal leukoencephalopathy...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Remove filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Add filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

Recent advice from the MHRA on the COVID-19 vaccines authorised for use in the UK, including advice for people with allergies and for women during pregnancy and breastfeeding.

Read Summary

Type:

Safety Alerts (Add filter)